Run,spots,bases,avgLength,size_MB,Experiment,LibraryName,LibraryStrategy,LibrarySelection,LibrarySource,LibraryLayout,InsertSize,InsertDev,Platform,Model,SRAStudy,BioProject,Study_Pubmed_id,ProjectID,Sample,BioSample,SampleType,TaxID,ScientificName,SampleName,CenterName,Submission,MONTH,YEAR,AUTHOR,sample_source,sample_title,source_name,cell line,cell type,genotype,treatment,time
SRR23073608,37667174,1883358700,50,734,SRX19026759,GSM6932801,OTHER,other,TRANSCRIPTOMIC,SINGLE,0,0,ILLUMINA,Illumina HiSeq 4000,SRP417361,PRJNA923627,1,"",SRS16445610,SAMN32727559,simple,9606,Homo sapiens,GSM6932801,Arc Institute,SRA1574205,01,2023,Makar,HL-60,"HL-60 RNA, decitabine, 72 hours, replicate 1",HL-60,HL-60,cancer cell line,WT,decitabine,72 hours
SRR23073609,36819405,1840970250,50,718,SRX19026760,GSM6932802,OTHER,other,TRANSCRIPTOMIC,SINGLE,0,0,ILLUMINA,Illumina HiSeq 4000,SRP417361,PRJNA923627,1,"",SRS16445609,SAMN32727558,simple,9606,Homo sapiens,GSM6932802,Arc Institute,SRA1574205,01,2023,Makar,HL-60,"HL-60 RNA, decitabine, 72 hours, replicate 2",HL-60,HL-60,cancer cell line,WT,decitabine,72 hours
SRR23073610,31864141,1593207050,50,619,SRX19026761,GSM6932803,OTHER,other,TRANSCRIPTOMIC,SINGLE,0,0,ILLUMINA,Illumina HiSeq 4000,SRP417361,PRJNA923627,1,"",SRS16445611,SAMN32727557,simple,9606,Homo sapiens,GSM6932803,Arc Institute,SRA1574205,01,2023,Makar,HL-60,"HL-60 RNA, DMSO, 72 hours, replicate 1",HL-60,HL-60,cancer cell line,WT,DMSO,72 hours
SRR23073611,44248511,2212425550,50,861,SRX19026762,GSM6932804,OTHER,other,TRANSCRIPTOMIC,SINGLE,0,0,ILLUMINA,Illumina HiSeq 4000,SRP417361,PRJNA923627,1,"",SRS16445612,SAMN32727556,simple,9606,Homo sapiens,GSM6932804,Arc Institute,SRA1574205,01,2023,Makar,HL-60,"HL-60 RNA, DMSO, 72 hours, replicate 2",HL-60,HL-60,cancer cell line,WT,DMSO,72 hours
SRR23073612,224347874,11217393700,50,3747,SRX19026763,GSM6932805,OTHER,other,TRANSCRIPTOMIC,SINGLE,0,0,ILLUMINA,Illumina HiSeq 4000,SRP417361,PRJNA923627,1,"",SRS16445613,SAMN32727555,simple,9606,Homo sapiens,GSM6932805,Arc Institute,SRA1574205,01,2023,Makar,HL-60,"HL-60 RPF, pooled",HL-60,HL-60,cancer cell line,WT,NA,72 hours
